J. Lykkesfeldt

Epidemiology · 2007–2018

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom J. Lykkesfeldt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Gerald I. Shulman

Who trusts J. Lykkesfeldt overall

  1. Xieyang Xu
  2. Aruna Kumar Panda

Papers from J. Lykkesfeldt's perspective

Ordered by how strongly the researchers J. Lykkesfeldt trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. (Gastroenterology)
  2. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. (Clinical Gastroenterology and Hepatology)
  3. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (Gastroenterology)
  4. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. (Journal of Clinical Investigation)
  5. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (Hepatology)
  6. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (Proceedings of the National Academy of Sciences of the United States of America)
  7. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (New England Journal of Medicine)
  8. Overproduction of large VLDL particles is driven by increased liver fat content in man (Diabetologia)
  9. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior (Science Signaling)
  10. Liver lipid metabolism. (Journal of animal physiology and animal nutrition)

Their papers